consumer-genomics
(4)
The Company That Turned 30 Billion Old Documents Into Your Family Story
It sells subscriptions to the past. With 30 billion records, the largest consumer DNA database around, and a growing stack of AI, Ancestry has quietly become one of the most durable businesses in consumer tech.
Genomelink
Genomelink is a consumer genomics platform - a self-described 'DNA App Store' - that lets people upload raw DNA data from services like 23andMe, AncestryDNA, and MyHeritage to unlock 400+ trait reports and deep ancestry breakdowns without buying another test kit. Operated by AWAKENS, Inc. and based in Berkeley, California, the company was founded by three genomics specialists from Japan who built it into one of the largest independent DNA-analysis sites while pushing into AI-powered genealogy (YourRoots) and clinical screening (T1D Scout).
Tomohiro Takano
Tomohiro Takano is the co-founder and CEO of Genomelink (operated by AWAKENS, Inc.), a Berkeley-based consumer genomics company building what he calls a 'DNA App Store.' The platform lets people who have taken tests from services like 23andMe or AncestryDNA upload their raw DNA data to unlock ancestry breakdowns, ancient-DNA comparisons, hundreds of trait analyses, and DNA matching. Takano started the company in 2016 as a weekend project in Japan with co-founders he met at university, moved to the Bay Area with no visa and little funding, and won a spot at Berkeley SkyDeck one day before the team was set to fly home and shut down. He frames himself as a 'risk manager' rather than a risk taker, and credits a liberal arts education for teaching him to ask the right questions.
Kian Sadeghi
Kian Sadeghi is the founder and CEO of Nucleus Genomics, a New York biotech building consumer whole-genome sequencing that aims to put your DNA in your pocket. He dropped out of the University of Pennsylvania at 20, taught himself genetics across 18 notebooks in a Brooklyn year he hid from his parents, won a Thiel Fellowship, and raised roughly $32 million from Peter Thiel, Alexis Ohanian's Seven Seven Six, Balaji Srinivasan and Founders Fund. His mission traces to a cousin who died young of a suspected heart-rhythm disorder, and his blunt embrace of 'genetic optimization' has made him one of the most debated young founders in biotech.